References
- Silverstein A, Doniger DE. Neurological complications of myelomatosis. Arch Neurol 1963;9:534–544.
- Sonneveld P, Jongen JL. Dealing with neuropathy in plasma-cell dyscrasias. Hematology Am Soc Hematol Educ Program 2010:423–430.
- Delforge M, Bladé J, Dimopoulos MA, . Treatment-related peripheral neuropathy in multiple myeloma:the challenge continues. Lancet Oncol 2010;11:1086–1095.
- Plasmati R, Pastorelli F, Cavo M, . Neuropathy in multiple myeloma treated with thalidomide: a prospective study. Neurology 2007;69:573–581.
- Richardson PG, Xie W, Mitsiades C, . Single-agent bortezomib in previously untreated multiple myeloma: efficacy, characterization of peripheral neuropathy, and molecular correlations with response and neuropathy. J Clin Oncol 2009;27:3518–3525.
- Ansari-Lari MA, Ali SZ. Fine needle aspiration of abdominal fat pad for amyloid detection: a clinically useful test? Diagn Cytopathol 2004;30:178–181.
- Kelly JJ, Kyle RA, Miles JM. The spectrum of peripheral neuropathy in myeloma. Neurology 1981;31:24–31.
- Vallat JM, Vital C. The spectrum of peripheral neuropathy in myeloma. Neurology 1981;31:1372–1373.
- Camacho J, Arnalich F, Anciones B, . The spectrum of neurological manifestations in myeloma. J Med 1985;16:597–611.
- Tosi P, Zamagni E, Cellini C, . Neurological toxicity of long term (> 1yr) thalidomide therapy in patients with multiple myeloma. Eur J Haematol 2005;74:212–216.
- Badros A, Goloubeva O, Dalal JS, . Neurotoxicity of bortezomib therapy in multiple myeloma: a single-center experience and review of the literature. Cancer 2007;110:1042–1049.
- Walsh JC. The neuropathy of multiple myeloma: an electrophysiological and histological study. Arch Neurol 1971;25:404–414.
- Latov N, Sherman WH, Nemni R, . Plasma cell dyscrasia and peripheral neuropathy with a monoclonal antibody to peripheral nerve myelin. N Engl J Med 1980;303:618–621.
- Davis LE, Drachman DB. Myeloma neuropathy: successful treatment of two patients and review of cases. Arch Neurol 1972;27:507–511.